Sunshine Biopharma, Inc. (SBFM)
2.71
-0.08
(-2.87%)
USD |
NASDAQ |
Nov 06, 16:00
2.76
+0.05
(+1.85%)
After-Hours: 05:51
Sunshine Biopharma Price : 2.71 for Nov. 6, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 06, 2026 | 2.73 | 2.85 | 2.68 | 2.71 | 36590.00 |
| Nov 05, 2026 | 2.69 | 2.91 | 2.53 | 2.79 | 80870.00 |
| Nov 04, 2026 | 2.77 | 2.83 | 2.59 | 2.65 | 88185.00 |
| Nov 03, 2026 | 2.70 | 2.87 | 2.67 | 2.74 | 54250.00 |
| Nov 02, 2026 | 2.91 | 2.958 | 2.66 | 2.75 | 68121.00 |
| Oct 30, 2026 | 3.10 | 3.21 | 2.65 | 2.93 | 113990.0 |
| Oct 29, 2026 | 2.94 | 3.443 | 2.93 | 3.33 | 182704.0 |
| Oct 28, 2026 | 3.00 | 3.14 | 2.88 | 3.11 | 495399.0 |
| Oct 27, 2026 | 2.65 | 3.34 | 2.65 | 2.96 | 586670.0 |
| Oct 26, 2026 | 3.06 | 3.11 | 2.580 | 2.65 | 91254.00 |
| Oct 23, 2026 | 3.40 | 3.444 | 2.622 | 3.00 | 113096.0 |
| Oct 22, 2026 | 3.33 | 3.80 | 3.155 | 3.34 | 155913.0 |
| Oct 21, 2026 | 4.562 | 4.60 | 4.304 | 4.308 | 18071.00 |
| Oct 20, 2026 | 4.68 | 4.876 | 4.276 | 4.40 | 33653.00 |
| Oct 19, 2026 | 4.477 | 5.04 | 4.336 | 4.836 | 63808.00 |
| Oct 16, 2026 | 4.42 | 4.584 | 4.10 | 4.436 | 44923.00 |
| Oct 15, 2026 | 4.588 | 4.60 | 3.71 | 4.60 | 78741.00 |
| Oct 14, 2026 | 4.70 | 4.956 | 4.242 | 4.86 | 86919.00 |
| Oct 13, 2026 | 5.782 | 5.974 | 4.60 | 4.726 | 242540.0 |
| Oct 12, 2026 | 6.188 | 6.59 | 5.624 | 6.04 | 123546.0 |
| Oct 09, 2026 | 8.024 | 8.044 | 6.624 | 6.756 | 347688.0 |
| Oct 08, 2026 | 9.416 | 9.416 | 7.604 | 8.60 | 5.923M |
| Oct 07, 2026 | 8.19 | 31.20 | 8.00 | 14.00 | 8.898M |
| Oct 06, 2026 | 8.636 | 8.68 | 7.128 | 7.958 | 226232.0 |
| Oct 05, 2026 | 9.70 | 9.998 | 8.234 | 8.402 | 106517.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ACADIA Pharmaceuticals, Inc. | 21.23 |
| Alnylam Pharmaceuticals, Inc. | 155.94 |
| Anika Therapeutics, Inc. | 14.55 |
| Savara, Inc. | 4.83 |
| Vericel Corp. | 54.62 |
Price Related Metrics
| PS Ratio | 0.0027 |
| Price to Book Value | 0.0118 |
| Earnings Yield | -7.55K% |
| Market Cap | 0.3236M |